Platelet reactivity to GPVI is enhanced in patients with diabetes and obesity [34,35], and platelet GPVI surface expression was significantly increased in patients with acute coronary syndrome, TIA, and stroke [36,37]. The gene discussed is GP6; the disease is diabetes mellitus.